In malignant tumors, the expression of NRP has also been confirmed in lung, pancreatic, prostate, breast, and ovarian cancer cells [11,12,13,14,15], and NRP-1 plays a mediator in tumor development associated with tumor initiation, tumor growth, and angiogenesis [10,11,16]. This evidence concerns the gene NRP1 and ovarian carcinoma.